Pharmacologic Pain Treatment of Musculoskeletal Disorders: Current Perspectives and Future Prospects
- 1 March 2001
- journal article
- review article
- Published by Wolters Kluwer Health in The Clinical Journal of Pain
- Vol. 17 (1) , 25-32
- https://doi.org/10.1097/00002508-200103000-00005
Abstract
The authors aimed to provide an educational update on the current evidence of the effectiveness of drug therapy in the treatment of musculoskeletal pain and to offer a perspective of possible future developments. The authors used a pragmatic review of data provided by available systematic reviews and seminal controlled studies pertaining to the treatment of regional musculoskeletal pain problems. Epidural steroids may offer limited, short-term benefit for sciatica. Local injections of steroids are either ineffective or provide short-lasting benefits. Nonsteroidal anti-inflammatory drugs and opioids reduce pain, but the effect size is modest. The literature does not support convincingly the use of antidepressants. Certain muscle relaxants may be useful in the treatment of back pain. Hyaluronic acid, neutraceutical agents, avocado-soybean unsaponifiable agents, oxaceprol and diacerein may be effective in the treatment of osteoarthritis, but the information regarding these new agents does not allow wholesale endorsement of these substances. Selective epidural injection of steroids at a target nerve root approached through the intervertebral foramin has the potential to replace the traditional epidural approach. Long-acting, C--fiber-specific local anesthetics are under investigation and could provide long-lasting pain relief without motor or sensory impairment. In the future, central hypersensitivity in chronic musculoskeletal pain might be treated using antagonists of the N-methyl-D-aspartate receptor. Cannabinoid agents produce antinociception and prevent experimentally induced hyperalgesia in animals, and they may find a role in pain management. Methods to optimize drug combinations are available. The effectiveness of the currently available drugs in the treatment of musculoskeletal pain conditions is disappointing. Recent developments may open new perspectives in this area of pain medicine.Keywords
This publication has 63 references indexed in Scilit:
- Diagnostic values of clinical diagnostic tests in subacromial impingement syndromeAnnals of the Rheumatic Diseases, 2000
- Diagnosing regional pain: the view from primary careBest Practice & Research Clinical Rheumatology, 1999
- Diagnostic classification of shoulder disorders: interobserver agreement and determinants of disagreementAnnals of the Rheumatic Diseases, 1999
- Musculoskeletal chronic pain in general practice: Studies of health care utilisation in comparison with pain prevalenceScandinavian Journal of Primary Health Care, 1999
- Management of osteoarthritis in the primary-care setting: An evidence-based approach to treatmentThe American Journal of Medicine, 1997
- Epidural Corticosteroid Injections for Sciatica Due to Herniated Nucleus PulposusNew England Journal of Medicine, 1997
- Efficacy of epidural steroid injections for low-back pain and sciatica: a systematic review of randomized clinical trialsPain, 1995
- THE PAINFUL SHOULDER: CAN CONSULTANTS AGREE?Rheumatology, 1995
- A Meta-Analysis on the Efficacy of Epidural Corticosteroids in the Treatment of SciaticaAnaesthesia and Intensive Care, 1995
- A COMPARISON OF THE TYPES OF EPIDURAL INJECTION COMMONLY USED IN THE TREATMENT OF LOW BACK PAIN AND SCIATICARheumatology, 1978